0.cached.png
By Newsweek Editors
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
When it comes to breast cancer, less may be more. Less time between treatments, that is. For years, oncologists have given patients chemo every three weeks. But results of a study announced last week at the San Antonio Breast Cancer Symposium suggest that women who get chemo every two weeks may live longer. Doctors have waited 21 days between doses because chemo causes the white blood count to dip dangerously low, leaving patients vulnerable to infection. Those on the dense-dose program take Neupogen, a drug that boosts white-blood-cell production. "The treatment is faster, has fewer side effects, and on top of it all, it's more effective," says study co-author Dr. Clifford Hudis of Memorial Sloan-Kettering hospital. Get more info at plwc.org in a few weeks.
Read More on News
View 0 Comments
Submit Correction
View Editorial & AI Guidelines